Thursday, May 16, 2019

Ola infused $60 million into its international operations

The capital invested only reflects additional costs of running local operations, marketing and incentives, according to sources aware of Ola’s plans. http://bit.ly/2VmQ04t https://ift.tt/eA8V8J

No comments:

Post a Comment

The US FDA cleared Neuralink rival Precision Neuroscience in late March 2025 to offer a less invasive brain implant; the device contains 1,024 metal electrodes (Ike Swetlitz/Bloomberg)

Ike Swetlitz / Bloomberg : The US FDA cleared Neuralink rival Precision Neuroscience in late March 2025 to offer a less invasive brain im...